StockNews.AISignal intelligence
Evolent Health, Inc. · NYSE · Healthcare
Browse public EVH signals with their source context and measured market impact. Open any signal for its permanent analysis page.
Evolent Health reported worse-than-expected Q3 results. EVH shares fell 33.6% in pre-market trading. Market futures and several stocks dropped today.
View signal analysis- EVH reported $639.65 million revenue, up 49.6% YoY with EPS of $0.34. - Revenue exceeded expectations by +6.33% and EPS by +61.90%. - Key metrics indicate strong underlying performance and future stock price projections. Price Impact Rating: Bearish Impact Horizon Rating: Short-term Type: Earnings
View signal analysis- EVH quarterly earnings: $0.34/share, beats estimates by 61.90%, revenues surpass estimates by 6.33%. - Company has beaten consensus EPS estimates four times in the past four quarters. - Future stock performance will depend on management's commentary on earnings call. - EVH shares down 17.4% YTD, underperforming S&P 500's gain of 8.8%. Price Impact Rating: Bearish Impact Horizon Rating: Short-term Type: Earnings
View signal analysis